Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Cambrex Corporation will expand research and development capabilities at its site in Paullo, Milan, Italy.
read more
Tuesday, January 30, 2018
Cambrex announced an investment to expand chemical and analytical development capabilities at its Charles City, Iowa plant.
read more
Wednesday, August 09, 2017
Cambrex Corporation announced that it is to invest $24 million in a new facility to manufacture highly potent APIs (HPAPIs) at its Charles City, Iowa plant.
read more
Cambrex announced that it is investing approximately $3 million to increase the capacity and efficiency of one of its cGMP manufacturing facilities at its site in Paullo, Milan, Italy.
read more
Wednesday, August 30, 2017
Cambrex, announced it is expanding its High Point, NC facility with the addition of a new $3.2 million, 11,000 sq.ft. analytical laboratory.
read more
Cambrex has completed the installation of multiple continuous flow reactor platforms at its High Point, NC facility.
read more
Cambrex announced it will start a $5 million expansion of laboratory facilities at its Karlskoga, Sweden site.
read more
Wednesday, November 08, 2017
Cambrex announced that it has completed an expansion of cGMP small scale capacity at its Charles City, Iowa plant.
read more
Cambrex announced that it is nearing the completion of a 5-year, $100-million-dollar investment strategy, one year ahead of schedule.
read more
Monday, November 21, 2022
Cambrex entered an agreement to acquire Snapdragon Chemistry, a leading US-based provider of chemical process development services to a broad range of emerging and established biopharma customers.
read more
Tuesday, September 25, 2018
Cambrex announced that it is to establish a center of excellence for API clinical supply and process development at its site in High Point, North Carolina.
read more
Wednesday, January 17, 2018
Cambrex held an opening ceremony with AstraZeneca at its Sweden site to mark the commencement of a long-term manufacturing agreement between the two companies for a key intermediate.
read more
Monday, November 04, 2013
Cambridge Major Laboratories, Inc. (“CML”), a global leader in pharmaceutical API development and manufacturing, and AAIPharma Services, Corp. (“AAIPharma”), a leading global provider of pharmaceutical analytical testing, product development and ...
read more
Tuesday, September 17, 2013
Global pharmaceutical chemistry leader Cambridge Major Laboratories, Inc. (CML) is pleased to announce the appointment of Dr. Mark Sawicki as Chief Business Officer. With executive leadership responsibility for the global sales and marketing ...
read more
Tuesday, October 22, 2013
Global pharmaceutical chemistry leader Cambridge Major Laboratories Europe, B.V. (CML-Europe) is pleased to announce the successful completion of its first Food and Drug Administration inspection. The inspection included a pre-approval inspection and...
read more